Report #2828981

Received Mar 3, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: —
Recovered: Unknown
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
RSV	RSV (AREXVY)	GLAXOSMITHKLINE BIOLOGICALS	UNK	UNK	—

Symptoms (1)

Diarrhoea

Symptom narrative

took arexvy and it gave Diarrhea; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of diarrhea in a patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis. On an unknown date, the patient received Arexvy. On an unknown date, an unknown time after receiving Arexvy, the patient experienced diarrhea (Verbatim: took arexvy and it gave Diarrhea). The outcome of the diarrhea was not reported. It was unknown if the reporter considered the diarrhea to be related to Arexvy. It was unknown if the company considered the diarrhea to be related to Arexvy. Additional Information: GSK Receipt Date: 19-FEB-2025 The patient received Arexvy and had diarrhea.